AUG 01, 2021 9:07 AM PDT

Berry Compound Reverses Parkinson's in Mice

WRITTEN BY: Annie Lennon

A naturally-occurring compound called farnesol found in berries and other fruits prevents and reverses Parkinson's-associated brain damage in mice. The study was published in Science Translational Medicine by researchers in the US and South Korea. 

Parkinson's disease occurs due to a loss of neurons in the brain that produce dopamine. This loss of neurons is thought to happen due to a build-up of PARIS, a protein that slows down the production of a protein called PGC-1alpha that shields brain cells from damaging oxygen molecules. Without PGC-1alpha, dopamine neurons die, leading to symptoms of Parkinson's disease.

In experiments, the researchers fed mice a farnesol-supplemented diet or a normal mouse diet for a week. They then gave the mice pre-formed fibrils of the protein alpha-synuclein, which mimic the effects of Parkinson's disease in the brain. In the end, they found that mice fed farnesol-rich diets performed an average of 100% better on strength and coordination tests used to detect the advancement of Parkinson's disease. 

The researchers later studied the brain tissue of mice from the two groups. In doing so, they found that those fed on farnesol had twice as many healthy dopaminergic neurons as those on the conventional mouse diet. Mice receiving supplements also had around 55% more PGC-1alpha in their brains than those on regular diets. 

The researchers later confirmed in chemical experiments that farnesol works by binding to PARIS and changing its shape to not interfere with PGC-1alpha production. 

The amount of farnesol currently consumed by people is unknown- both in natural and synthetic form. Moreover, safe doses of farnesol for humans are yet to be determined by clinical trials. This means that further research is needed before farnesol supplementation could begin to be considered for humans to prevent or reverse Parkinson's disease. 

 

Sources: Science Translational MedicinePubChemNeuroscience News

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
JUN 29, 2021
Technology
Can Digital Simulations Replace Real People in Clinical Trials? Maybe
JUN 29, 2021
Can Digital Simulations Replace Real People in Clinical Trials? Maybe
Clinical trials are essential to the development of new drugs and medicines, and they offer new insights every day about ...
JUL 20, 2021
Technology
Artificial Intelligence Predicts Which Drug Candidates Will Be Successful In Clinical Trials
JUL 20, 2021
Artificial Intelligence Predicts Which Drug Candidates Will Be Successful In Clinical Trials
Researchers are leveraging artificial intelligence and machine learning to help improve the rate at which drugs move suc ...
JUL 29, 2021
Drug Discovery & Development
What is Ivermectin and Can it Treat COVID?
JUL 29, 2021
What is Ivermectin and Can it Treat COVID?
Lab tests in 2020 found that the widely available drug ivermectin had a weak effect on the SARS-CoV-2 virus and that unf ...
AUG 13, 2021
Cancer
Ultrasound Triggers Immunotherapy to Destroy Tumors
AUG 13, 2021
Ultrasound Triggers Immunotherapy to Destroy Tumors
An immunotherapy engineered to be triggered by ultrasound beams significantly slows the growth of cancerous tumors in mi ...
AUG 19, 2021
Cancer
Japanese Berry Vine Could Treat Lung Cancer
AUG 19, 2021
Japanese Berry Vine Could Treat Lung Cancer
A berry-producing vine in Japan has shown promise in mouse models for treating lung cancer. The corresponding study was ...
SEP 20, 2021
Genetics & Genomics
Clinical Trial of CRISPR-Based HIV Treatment Set to Begin
SEP 20, 2021
Clinical Trial of CRISPR-Based HIV Treatment Set to Begin
Human immunodeficiency virus (HIV) is a retrovirus, which is a type of virus that can write its genetic material into th ...
Loading Comments...